AR Enhanced Pictorial Warnings on Smoking Cessation

May 19, 2023 updated by: Dr. Wang Man-Ping, The University of Hong Kong

Mobile Phone Based Personalized and Interactive Augmented Reality (AR) Pictures on Enhancing Brief Advice Model for Smoking Cessation: a Pilot Randomized Controlled Trial

This pilot randomized controlled trail aims to test the effects of AR enhanced pictorial effects in harms of smoking and benefit of smoking cessation.

Study Overview

Detailed Description

Conventional health warnings on smoking harms mostly include pictures showing smoking consequences such as lung diseases, peripheral vascular diseases, aging, skin lesions, and benefit of quitting such as improved cardiopulmonary functions, skin conditions and risk of diseases, etc. The effects of the information are limited by the generic messages, unattractive images, and lack of interaction. This proposal aims to enhance the "Warn" and "Advice" materials using mobile phone-based augmented reality (AR) technologies to provide personalized, interactive, and attractive images to encourage smokers to quit smoking.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong
        • School of Nursing, The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Hong Kong adults aged 18 or above;
  • Smoke at least 1 cigarette daily in the past 30 days;
  • Own a smartphone and familiar with instant messaging apps;
  • Able to read and communicate in Chinese.

Exclusion Criteria:

  • Participate in other smoking cessation services or projects

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AR group
Brief AWARD advice + active referral + leaflet + 3 months chat-based support with AR pictures
The AWARD advice includes: (1) Ask about smoking history; (2) Warn about the high risk of smoking; (3) Advise to quit or reduce smoking as soon as possible; (4) Refer smokers to smoking cessation services (with a referral card); (5) Do it again: to repeat the intervention.
Participants in the intervention group will receive 3 months of chat-based support through Instant Messaging apps (e.g., WhatsApp, WeChat). The support mainly includes (1) regular messages on health warnings, benefits and methods of quitting, coping craving approach, and promotion to use the SC services; (2) real-time, personalized, and interactive behavioral and psychosocial support through Instant Messaging apps.
Leaflet on harms of smoking
AR images of the harms of smoking and the benefit of abstinence.
Active Comparator: Control group
Brief AWARD advice + active referral + leaflet + 3 months chat-based support
The AWARD advice includes: (1) Ask about smoking history; (2) Warn about the high risk of smoking; (3) Advise to quit or reduce smoking as soon as possible; (4) Refer smokers to smoking cessation services (with a referral card); (5) Do it again: to repeat the intervention.
Participants in the intervention group will receive 3 months of chat-based support through Instant Messaging apps (e.g., WhatsApp, WeChat). The support mainly includes (1) regular messages on health warnings, benefits and methods of quitting, coping craving approach, and promotion to use the SC services; (2) real-time, personalized, and interactive behavioral and psychosocial support through Instant Messaging apps.
Leaflet on harms of smoking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported past 7-day point prevalence abstinence
Time Frame: 3 months after baseline
Abstain from smoking in the past 7 days
3 months after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported past 7-day point prevalence abstinence
Time Frame: 1 months after baseline
Abstain from smoking in the past 7 days
1 months after baseline
Self-reported smoking reduction by at least 50%
Time Frame: 3 months after baseline
Defined by at least 50% reduction in baseline daily cigarette consumption
3 months after baseline
Self-reported smoking reduction by at least 50%
Time Frame: 1 months after baseline
Defined by at least 50% reduction in baseline daily cigarette consumption
1 months after baseline
Self-reported quit attempts
Time Frame: 3 months after baseline
Defined by abstinence for at least 24 hours
3 months after baseline
Self-reported quit attempts
Time Frame: 1 months after baseline
Defined by abstinence for at least 24 hours
1 months after baseline
Recall of pictorial warnings
Time Frame: 3 months after baseline
Defined by the recall of the quitline on warning pictures
3 months after baseline
Recall of pictorial warnings
Time Frame: 1 months after baseline
Defined by the recall of the quitline on warning pictures
1 months after baseline
Attention of pictorial warnings
Time Frame: 1 months after baseline
Defined by notice of pictorial warning
1 months after baseline
Attention of pictorial warnings
Time Frame: 3 months after baseline
Defined by notice of pictorial warning
3 months after baseline
Self-reported intention to quit
Time Frame: 1 months after baseline
Defined by readiness to quit in 30 days
1 months after baseline
Self-reported intention to quit
Time Frame: 3 months after baseline
Defined by readiness to quit in 30 days
3 months after baseline
Reactions to the pictorial warnings
Time Frame: 3 months after baseline
Defined by behaviors to avoid seeing pictorial warnings
3 months after baseline
Reactions to the pictorial warnings
Time Frame: 1 months after baseline
Defined by behaviors to avoid seeing pictorial warnings
1 months after baseline
Perceived effectiveness of AR images
Time Frame: 1 months after baseline
Defined by ratings on the effectiveness of AR images to encourage quitting
1 months after baseline
Perceived effectiveness of AR images
Time Frame: 3 months after baseline
Defined by ratings on the effectiveness of AR images to encourage quitting
3 months after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Man Ping Wang, PhD, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 23, 2021

Primary Completion (Actual)

March 31, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

March 24, 2021

First Submitted That Met QC Criteria

March 31, 2021

First Posted (Actual)

April 2, 2021

Study Record Updates

Last Update Posted (Actual)

May 22, 2023

Last Update Submitted That Met QC Criteria

May 19, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Pictorial warning AR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Brief AWARD advice and active referral to somking cessation services

3
Subscribe